Assessing the long-term effectiveness of cladribine vs. placebo in the relapsing-remitting multiple sclerosis CLARITY randomized controlled trial and CLARITY extension using treatment switching adjustment methods

Bell Gorrod, H. orcid.org/0000-0001-8054-8073, Latimer, N.R., Damian, D. et al. (3 more authors) (2019) Assessing the long-term effectiveness of cladribine vs. placebo in the relapsing-remitting multiple sclerosis CLARITY randomized controlled trial and CLARITY extension using treatment switching adjustment methods. Advances in Therapy. ISSN 0741-238X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Springer Healthcare Ltd., part of Springer Nature. This is an author-produced version of a paper subsequently published in Advances in Therapy. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: multiple sclerosis; treatment switching; rank-preserving structural failure time model; iterative parameter estimation; adjustment methods; time-to-event
Dates:
  • Accepted: 24 October 2019
  • Published (online): 7 November 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 06 Nov 2019 15:31
Last Modified: 07 Nov 2020 01:38
Status: Published online
Publisher: Springer
Refereed: Yes
Identification Number: https://doi.org/10.1007/s12325-019-01140-z

Share / Export

Statistics